Eli Lilly and Co (LLY.N)

LLY.N on New York Stock Exchange

63.64USD
2:42pm EDT
Price Change (% chg)

$0.00 (+0.00%)
Prev Close
$63.64
Open
$63.84
Day's High
$64.14
Day's Low
$63.44
Volume
334,831
Avg. Vol
1,237,051
52-wk High
$64.14
52-wk Low
$47.53

LLY.N

Chart for LLY.N

About

Eli Lilly and Company, discovers, develops, manufactures, and sells products, in one business segment, pharmaceutical products. The Company also has an animal health business segment. It manufactures and distributes its products through facilities in the United States, Puerto Rico, and 15 other countries. Its products are sold... (more)

Overall

Beta: 0.43
Market Cap (Mil.): $71,241.87
Shares Outstanding (Mil.): 1,119.45
Dividend: 0.49
Yield (%): 3.08

Financials

  LLY.N Industry Sector
P/E (TTM): 17.79 35.59 35.92
EPS (TTM): 3.58 -- --
ROI: 14.64 18.98 18.26
ROE: 23.22 19.75 19.14
Search Stocks

Spooked by probes, pharma executives ask: should I leave China?

SHANGHAI - China's crackdown on corruption in the pharmaceutical sector has frightened foreign executives so much that some fear they could be jailed and have asked their lawyers if they should leave the country for six months. Others are thinking of going for good.

12 Jun 2014

Spooked by probes, pharma executives ask: should I leave China?

* Charges against GSK's Mark Reilly shocked business community

12 Jun 2014

Sanofi, Lilly pursue Cialis over-the-counter approval

PARIS - Sanofi and Eli Lilly and Co have agreed to pursue regulatory approval for over-the-counter sales of erectile dysfunction treatment Cialis, the French and U.S. drugmakers said in a statement on Wednesday.

28 May 2014

Sanofi, Lilly pursue Cialis over-the-counter approval

PARIS, May 28 - Sanofi and Eli Lilly and Co have agreed to pursue regulatory approval for over-the-counter sales of erectile dysfunction treatment Cialis, the French and U.S. drugmakers said in a statement on Wednesday.

28 May 2014

UPDATE 1-A bitter pill as China crackdowns squeeze pharma margins

SHANGHAI, May 25 - A crackdown on corruption and pricing in China's fast-growing pharmaceutical market has squeezed profits and margins, raising a red flag to global Big Pharma that the days of easy growth in the country may be over.

26 May 2014

RPT-A bitter pill as China crackdowns squeeze pharma margins

(Repeats article first published on Sunday. No changes to text.)

25 May 2014

A bitter pill as China crackdowns squeeze pharma margins

SHANGHAI - A crackdown on corruption and pricing in China's fast-growing pharmaceutical market has squeezed profits and margins, raising a red flag to global Big Pharma that the days of easy growth in the country may be over.

24 May 2014

A bitter pill as China crackdowns squeeze pharma margins

SHANGHAI - A crackdown on corruption and pricing in China's fast-growing pharmaceutical market has squeezed profits and margins, raising a red flag to global Big Pharma that the days of easy growth in the country may be over.

24 May 2014

A bitter pill as China crackdowns squeeze pharma margins

SHANGHAI, May 25 - A crackdown on corruption and pricing in China's fast-growing pharmaceutical market has squeezed profits and margins, raising a red flag to global Big Pharma that the days of easy growth in the country may be over.

24 May 2014

UPDATE 2-China anti-graft watchdog visits Roche amid pharma crackdown

* China cracking down on wider pharma sector (Adds comment from SAIC, updates shares)

22 May 2014

Competitors

  Price Change
Takeda Pharmaceutical Co Ltd (4502.T) ¥4,673 +3.00
Johnson & Johnson (JNJ.N) $102.30 +1.03
Pfizer Inc. (PFE.N) $30.50 +0.15
Novartis AG (NOVN.VX) CHF80.55 +0.90
Merck & Co., Inc. (MRK.N) $58.38 +0.38
Abbott Laboratories (ABT.N) $43.15 +0.19
Sanofi SA (SASY.PA) €76.99 +1.18
AstraZeneca plc (AZN.L) 4,426.00p +36.00
GlaxoSmithKline plc (GSK.L) 1,555.00p -2.00
Bristol-Myers Squibb Co (BMY.N) $49.19 +0.27

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Plunkett Research, Ltd.
$99.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks